aspen-05 preliminary data: evorpacept plus azacitidine and venetoclax in patients with aml
Published 1 year ago • 75 plays • Length 3:30Download video MP4
Download video MP3
Similar videos
-
2:37
maintenance venetoclax and 5-azacytidine in patients with aml
-
5:36
venetoclax and azacitidine in mds patients
-
1:59
phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
0:44
predictors of poor response to azacitidine, venetoclax, and magrolimab in tp53-mutated aml
-
5:52
aspen lida overview
-
7:50
which aml patients benefit most from venetoclax treatment?
-
14:38
case report ophthalmologic presentations of incontinentia pigmenti 1080p
-
1:36
eprenetapopt plus venetoclax and azacitidine in the treatment of tp53-mutated aml
-
5:31
the role of venetoclax in older patients with aml
-
1:07
preliminary promise for venetoclax and 3 7 in untreated aml
-
3:52
venetoclax & aml
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:50
pevonedistat, venetoclax and azacitidine for older aml patients
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
2:25
venetoclax for aml
-
3:08
venetoclax-idh inhibitor combination therapy for aml
-
4:20
updates from a study evaluating astx727 venetoclax for patients with aml
-
2:12
aml: options after venetoclax-based regimen failure
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
1:54
a novel clinical trial endpoint for acute gvhd